Rongrong Wang1, Shirui Han2, Amjad Khan2, Xue Zhang1. 1. 1 Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, McKusick-Zhang Center for Genetic Medicine, School of Basic Medicine Peking Union Medical College , Beijing, China . 2. 2 The Research Center for Medical Genomics, China Medical University , Shenyang, China .
Abstract
AIM: To investigate the causative genetic mutations in 12 Pakistani families with nonsyndromic or syndromic hearing loss. METHODS: Mutations in the most common causative gene for hearing loss, GJB2, were evaluated by Sanger sequencing. Targeted next-generation sequencing or whole-exome sequencing was used to analyze the genomic DNA samples from 11 probands with hearing loss. Sanger sequencing was performed to verify all identified variants. RESULTS: We found pathogenic, or likely to be pathogenic, mutations in all 12 families, including six known mutations in GJB2, SLC26A4, LHFPL5, and USH2A and eight novel mutations in ESPN, MYO7A, LRTOMT, PCDH15, USH2A, or EPS8L2. Notably, four compound heterozygous mutations in the MYO7A and USH2A genes were detected in two consanguineous families. In addition, the novel frameshift mutation in EPS8L2 was first documented in Pakistan. CONCLUSIONS: Our study increases the spectrum of mutations associated with hearing loss in the Pakistani population. In addition, our study highlights the fact that compound heterozygous mutations, although rare, can occur in consanguineous families.
AIM: To investigate the causative genetic mutations in 12 Pakistani families with nonsyndromic or syndromic hearing loss. METHODS: Mutations in the most common causative gene for hearing loss, GJB2, were evaluated by Sanger sequencing. Targeted next-generation sequencing or whole-exome sequencing was used to analyze the genomic DNA samples from 11 probands with hearing loss. Sanger sequencing was performed to verify all identified variants. RESULTS: We found pathogenic, or likely to be pathogenic, mutations in all 12 families, including six known mutations in GJB2, SLC26A4, LHFPL5, and USH2A and eight novel mutations in ESPN, MYO7A, LRTOMT, PCDH15, USH2A, or EPS8L2. Notably, four compound heterozygous mutations in the MYO7A and USH2A genes were detected in two consanguineous families. In addition, the novel frameshift mutation in EPS8L2 was first documented in Pakistan. CONCLUSIONS: Our study increases the spectrum of mutations associated with hearing loss in the Pakistani population. In addition, our study highlights the fact that compound heterozygous mutations, although rare, can occur in consanguineous families.
Authors: Zubair M Ahmed; Richard Goodyear; Saima Riazuddin; Ayala Lagziel; P Kevin Legan; Martine Behra; Shawn M Burgess; Kathryn S Lilley; Edward R Wilcox; Sheikh Riazuddin; Andrew J Griffith; Gregory I Frolenkov; Inna A Belyantseva; Guy P Richardson; Thomas B Friedman Journal: J Neurosci Date: 2006-06-28 Impact factor: 6.167
Authors: J D Eudy; M D Weston; S Yao; D M Hoover; H L Rehm; M Ma-Edmonds; D Yan; I Ahmad; J J Cheng; C Ayuso; C Cremers; S Davenport; C Moller; C B Talmadge; K W Beisel; M Tamayo; C C Morton; A Swaroop; W J Kimberling; J Sumegi Journal: Science Date: 1998-06-12 Impact factor: 47.728
Authors: Saima Anwar; Saima Riazuddin; Zubair M Ahmed; Saba Tasneem; Shahid Y Khan; Andrew J Griffith; Thomas B Friedman; Sheikh Riazuddin Journal: J Hum Genet Date: 2009-03-13 Impact factor: 3.172
Authors: Mohsin Shahzad; Theru A Sivakumaran; Tanveer A Qaiser; Julie M Schultz; Zawar Hussain; Megan Flanagan; Munir A Bhinder; Diane Kissell; John H Greinwald; Shaheen N Khan; Thomas B Friedman; Kejian Zhang; Saima Riazuddin; Sheikh Riazuddin; Zubair M Ahmed Journal: Otolaryngol Head Neck Surg Date: 2013-06-14 Impact factor: 3.497
Authors: S Naz; A J Griffith; S Riazuddin; L L Hampton; J F Battey; S N Khan; S Riazuddin; E R Wilcox; T B Friedman Journal: J Med Genet Date: 2004-08 Impact factor: 6.318
Authors: Takeshi Kawakami; Vandana Raghavan; Alison L Ruhe; Meghan K Jensen; Ausra Milano; Thomas C Nelson; Adam R Boyko Journal: PLoS One Date: 2022-04-06 Impact factor: 3.240